| March 2022 | 
		      For Review at March 24, 2022, Meeting: Acne Agents | 
          
             
		      | March 2022 | 
		      For Review at March 24, 2022, Meeting: Attention-Deficit/Hyperactivity Disorder (ADHD) Agents | 
          
             
		      | March 2022 | 
		      For Review at March 24, 2022, Meeting: Dopamine Agents | 
          
            
		      | March 2022 | 
		      For Review at March 24, 2022, Meeting: Multiple Sclerosis Agents | 
          
            
		      | March 2022 | 
		      For Review at March 24, 2022, Meeting: Ophthalmic Anti-Allergy | 
          
              
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Angiotensin-Converting Enzyme (ACE) Inhibitors | 
          
              
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Antipsychotics, Atypicals | 
          
              
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Calcitonin Gene Related Peptide (CGRP) Inhibitors | 
          
              
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Cardiovascular Agents, Miscellaneous | 
          
             
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Electrolyte Depleters | 
          
            
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Glucagon Agents | 
          
             
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Incretin Mimetics and Amylinomimetics | 
          
             
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Movement Disorder Agents | 
          
             
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Neuropathic Pain and Fibromyalgia Agents | 
          
             
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Ophthalmic Immunomodulators | 
          
            
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Opioid Use Disorder Agents | 
          
            
		      | December 2021 | 
		      For Review at December 9, 2021, Meeting: Urinary Antispasmodics | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Acne Agents | 
          
             
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Attention-Deficit/Hyperactivity Disorder (ADHD) Agents | 
          
             
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Bile Acid Sequestrants | 
          
             
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Calcitonin Gene Related Peptide (CGRP) Inhibitors | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Carbidopa/Levodopa Agents | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Cystic Fibrosis – Inhaled Antibiotics | 
          
             
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Gout – Anti-Gout Agents | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Immunomodulators | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Incretin Mimetics and Amylinomimetics | 
          
             
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Insulin and Combination Agents | 
          
             
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Lidocaine (Added to this list on August 27, 2021) | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Multiple Sclerosis Agents | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Narcolepsy Agents | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Ophthalmic Anti-Allergy | 
          
             
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Pancreatic Enzymes | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Respiratory Beta-Agonist Combination Agents | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Respiratory Beta-Agonists | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Respiratory Corticosteroids | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Statins (HMG-CoA Reductase Inhibitors) | 
          
            
		      | September 2021 | 
		      For Review at September 23, 2021, Meeting: Triptans | 
          
          
		      | June 2021 | 
		      For Review at June 24, 2021, Meeting: Antipsychotics, Atypicals | 
          
          
		      | June 2021 | 
		      For Review at June 24, 2021, Meeting: Calcitonin Gene Related Peptide (CGRP) Inhibitors | 
          
          
		      | June 2021 | 
		      For Review at June 24, 2021, Meeting: Familial Hypercholesterolemia Agents | 
          
          
		      | June 2021 | 
		      For Review at June 24, 2021, Meeting: Irritable Bowel Syndrome and Constipation Agents | 
          
          
		      | June 2021 | 
		      For Review at June 24, 2021, Meeting: Ophthalmic Agents, Intraocular Pressure (IOP)-Modifying | 
          
          
		      | June 2021 | 
		      For Review at June 24, 2021, Meeting: Opioids, Long Acting | 
          
          
		      | June 2021 | 
		      For Review at June 24, 2021, Meeting: Scabicides and Pediculicides | 
          
          
		      | March 2021 | 
		      For Review at March 25, 2021, Meeting: Antiemetics | 
          
          
		      | March 2021 | 
		      For Review at March 25, 2021, Meeting: Beta-Adrenergic Blocking Agents | 
          
          
		      | March 2021 | 
		      For Review at March 25, 2021, Meeting: Insulin and Combination Agents | 
          
          
		      | March 2021 | 
		      For Review at March 25, 2021, Meeting: Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors | 
          
          
		      | March 2021 | 
		      For Review at March 25, 2021, Meeting: Urinary Antispasmodics | 
          
          
		      | December 2020 | 
		      For Review at December 10, 2020, Meeting: Anticonvulsants | 
          
          
		      | December 2020 | 
		      For Review at December 10, 2020, Meeting: Calcitonin Gene Related Peptide (CGRP) Inhibitors | 
          
          
		      | December 2020 | 
		      For Review at December 10, 2020, Meeting: GnRH Modulators | 
          
          
		      | December 2020 | 
		      For Review at December 10, 2020, Meeting: Multiple Sclerosis Agents | 
          
          
		      | December 2020 | 
		      For Review at December 10, 2020, Meeting: Ophthalmic Immunomodulators | 
          
          
		      | December 2020 | 
		      For Review at December 10, 2020, Meeting: Respiratory Beta-Agonist Combination Agents | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Acne Agents | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Antiasthmatic – Monoclonal Antibodies | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Anticonvulsants | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Antiemetics | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Anti-gout Agents | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Antihistamines, Second-generation | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Antihyperlipidemics, Miscellaneous | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Antivirals, Topical | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Attention-Deficit/Hyperactivity Disorder (ADHD) Agents | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Benign Prostatic Hyperplasia Agents | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Calcium Channel Blockers | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Cephalosporins, Third-generation | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Electrolyte Depleters | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Immunomodulators | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Incretin Mimetics and Amylinomimetics | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Inflammatory Bowel Disease Agents | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Insulin and Combination Agents | 
          
          
		      | September 2020 | 
		      For Review at September 24, 2020, Meeting: Irritable Bowel Syndrome and Constipation Agents | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Multiple Sclerosis Agents | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Neuropathic Pain and Fibromyalgia Agents | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Ophthalmic Corticosteroids | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Ophthalmics, Antibiotics and Combinations | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Opioid Use Disorder Agents | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Platelet Aggregation Inhibitors | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Pulmonary Arterial Hypertension Agents | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Respiratory Beta-Agonist Combination Agents | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Respiratory Beta-Agonists | 
         
         
		    | September 2020 | 
		    For Review at September 24, 2020, Meeting: Sodium-Glucose Cotransporter-2 Inhibitors | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Statins (HMG-CoA Reductase Inhibitors) | 
         
         
		     | September 2020 | 
		     For Review at September 24, 2020, Meeting: Urinary Antispasmodics | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Attention-Deficit/Hyperactivity Disorder (ADHD) Agents | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Atypical Antipsychotics | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Calcitonin Gene Related Peptide (CGRP) Inhibitors | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Calcium Channel Blockers | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Glucagon Agents | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Insulin and Combination Agents | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Multiple Sclerosis Agents | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Narcolepsy Agents | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Ophthalmic Agents, Intraocular Pressure (IOP)-Modifying | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Ophthalmic Anti-Allergy | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Reyvow™ (Lasmiditan) | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Sodium-Glucose Cotransporter-2 Inhibitors) | 
         
         
		    | June 2020 | 
		    For Review at June 25, 2020, Meeting: Triptans | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Angiotensin-Converting Enzyme (ACE) Inhibitors | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Antiasthmatic – Monoclonal Antibodies | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Anticonvulsants | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Antipsoriatic Agents | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Calcitonin Gene Related Peptide (CGRP) Inhibitors | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Incretin Mimetics and Amylinomimetics | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Intranasal Allergic Rhinitis Agents | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Opioids, Long Acting | 
         
         
		    | March 2020 | 
		    For Review at March 26, 2020, Meeting: Opioid Use Disorder Agents | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Antiasthmatic – Monoclonal Antibodies | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Anticonvulsants | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Anti-Migraine Agents (Triptans) | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Antipsoriatic Agents | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Calcitonin Gene Related Peptide (CGRP) Inhibitors | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Incretin Mimetics and Amylinomimetics | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Intranasal Allergic Rhinitis Agents | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Opioids, Long Acting | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Opioids, Short Acting | 
         
         
		    | December  2019 | 
		    For Review at December 5, 2019, Meeting: Opioid Use Disorder Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Angiotensin II Receptor Blockers (ARBs) | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Antiemetics | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Anti-inflammatory Agents – Misc., Topical | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Anti-migraine Agents (Triptans) | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Antivirals, Influenza | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Antivirals, Topical | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Attention-Deficit/Hyperactivity Disorder (ADHD) Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Atypical Antipsychotics | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Biguanides | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Calcitonin Gene Related Peptide (CGRP) Inhibitors | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Calcium Channel Blockers | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Erythropoiesis Stimulating Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Hepatitis C Direct-Acting Antivirals | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Immunomodulators | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Inflammatory Bowel Disease Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Incretin Mimetics and Amylinomimetics | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Inhaled Aminoglycosides | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Insulin and Combination Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Macrolides | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Meglitinides | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Narcolepsy Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Omega-3 Fatty Acids | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Opioids, Long Acting | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Opioids, Short Acting | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Opioid Use Disorder Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Proton Pump Inhibitors | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Pulmonary Arterial Hypertension Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Respiratory Beta-Agonist Combination Agents | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Scabicides and Pediculicides | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Sodium-Glucose Cotransporter-2 Inhibitors | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Statins (HMG-CoA Reductase Inhibitors) | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Sulfonylureas | 
         
         
		    | September  2019 | 
		    For Review at September 26, 2019, Meeting: Thiazolidinediones |